Baxter International will report its quarterly earnings this Thursday before the market opens. The company beat revenue expectations last quarter with $2.70 billion, up 2.9% year on year, and also exceeded analysts' EPS and full-year EPS guidance estimates. For the upcoming report, the market expects flat revenue year on year, a slowdown from the 4.3% growth in the same quarter last year. Analysts have largely maintained their estimates over the past 30 days, though Baxter has missed revenue estimates multiple times in the last two years. Peers Abbott Laboratories and Intuitive Surgical recently reported revenue growth of 13% and 18.5% respectively, both beating expectations. Baxter shares have risen 11.3% over the past month, and the average analyst price target is $22.96 compared to the current share price of $24.50.
Baxter International IncUpcoming earnings report with mixed expectations; past beat but revenue growth expected to slow, and stock has risen recently.
Abbott Laboratories
Intuitive Surgical Inc